alexa Bioequivalence Inspection
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th World congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit
June 26-27, 2017 San Diego, USA

Ashish A Mungantiwar
Macleods Pharmaceuticals Ltd., India
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X-C1-029
Abstract
Statement of the Problem: Bioequivalence study is conducted on healthy volunteer/patient to compare pharmacokinetic parameter of test product and reference product. Generic company conducting/sponsoring the study should be aware of risks of rejection and non-compliance. Methodology & Theoretical Orientation: Current topic will cover list of inspection findings from various regulatory agencies like US, EU and WHO and how to be ready for unannounced inspection, presentation will discuss current inspection trends and queries asked during dossier assessment. Conclusion & Significance: This presentation will critically review inspector and assessors expectation on bioequivalence Understanding such expectation will help for early and successful approval of the product.
Biography

Ashish Mungantiwar is a PhD Pharmacologist by profession. He is working as President Medical Services in Macleods Pharmaceuticals Limited. He heads various departments like Bioequivalence, Clinical Trial and Pharmacovigilance. As Head of Bioequivalence he served as Study Director for more than 2000 bioequivalence studies. He has successfully handled more than 25 inspections from USFDA, WHO, EU and ANVISA. He has attended meeting with regulators of WHO and EU during approval process of the product. In order to keep his academic temperament alive, he works as PhD guide in industry and has already guided 5 PhD students. He is invited speaker in various international conferences.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords